Daiichi Sankyo Venture Subsidiary Focuses On Rare Disease Niche
This article was originally published in PharmAsia News
Executive Summary
Kobe-based Asubio Pharma, a venture firm and subsidiary of Daiichi Sankyo has turned its attention to the research and development of treatments and diagnostics for rare diseases